These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 17548587

  • 1. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells.
    Treml LS, Carlesso G, Hoek KL, Stadanlick JE, Kambayashi T, Bram RJ, Cancro MP, Khan WN.
    J Immunol; 2007 Jun 15; 178(12):7531-9. PubMed ID: 17548587
    [Abstract] [Full Text] [Related]

  • 2. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
    Katsenelson N, Kanswal S, Puig M, Mostowski H, Verthelyi D, Akkoyunlu M.
    Eur J Immunol; 2007 Jul 15; 37(7):1785-95. PubMed ID: 17557373
    [Abstract] [Full Text] [Related]

  • 3. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
    Ozcan E, Garibyan L, Lee JJ, Bram RJ, Lam KP, Geha RS.
    J Allergy Clin Immunol; 2009 Jun 15; 123(6):1277-86.e5. PubMed ID: 19427685
    [Abstract] [Full Text] [Related]

  • 4. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
    Kanswal S, Katsenelson N, Selvapandiyan A, Bram RJ, Akkoyunlu M.
    J Immunol; 2008 Jul 15; 181(2):976-90. PubMed ID: 18606649
    [Abstract] [Full Text] [Related]

  • 5. Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.
    Ozcan E, Rauter I, Garibyan L, Dillon SR, Geha RS.
    J Allergy Clin Immunol; 2011 Sep 15; 128(3):601-9.e1-4. PubMed ID: 21741080
    [Abstract] [Full Text] [Related]

  • 6. The role of BLyS/BLyS receptors in anti-chromatin B cell regulation.
    Hondowicz BD, Alexander ST, Quinn WJ, Pagán AJ, Metzgar MH, Cancro MP, Erikson J.
    Int Immunol; 2007 Apr 15; 19(4):465-75. PubMed ID: 17369193
    [Abstract] [Full Text] [Related]

  • 7. Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.
    Banday VS, Thyagarajan R, Sundström M, Lejon K.
    Immunology; 2016 Nov 15; 149(3):297-305. PubMed ID: 27444337
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS.
    Wu Y, Bressette D, Carrell JA, Kaufman T, Feng P, Taylor K, Gan Y, Cho YH, Garcia AD, Gollatz E, Dimke D, LaFleur D, Migone TS, Nardelli B, Wei P, Ruben SM, Ullrich SJ, Olsen HS, Kanakaraj P, Moore PA, Baker KP.
    J Biol Chem; 2000 Nov 10; 275(45):35478-85. PubMed ID: 10956646
    [Abstract] [Full Text] [Related]

  • 9. No evidence that soluble TACI induces signalling via membrane-expressed BAFF and APRIL in myeloid cells.
    Nys J, Smulski CR, Tardivel A, Willen L, Kowalczyk C, Donzé O, Huard B, Hess H, Schneider P.
    PLoS One; 2013 Nov 10; 8(4):e61350. PubMed ID: 23620746
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.
    Schneider P, Takatsuka H, Wilson A, Mackay F, Tardivel A, Lens S, Cachero TG, Finke D, Beermann F, Tschopp J.
    J Exp Med; 2001 Dec 03; 194(11):1691-7. PubMed ID: 11733583
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
    Moreaux J, Sprynski AC, Dillon SR, Mahtouk K, Jourdan M, Ythier A, Moine P, Robert N, Jourdan E, Rossi JF, Klein B.
    Eur J Haematol; 2009 Aug 03; 83(2):119-29. PubMed ID: 19456850
    [Abstract] [Full Text] [Related]

  • 18. [Progress in the study of BLyS and APRIL on regulating T cell responses in rheumatoid arthritis].
    Chang Y, Wei W.
    Yao Xue Xue Bao; 2013 Jul 03; 48(7):979-85. PubMed ID: 24133964
    [Abstract] [Full Text] [Related]

  • 19. The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.
    Lyu MA, Cheung LH, Hittelman WN, Marks JW, Aguiar RC, Rosenblum MG.
    Mol Cancer Ther; 2007 Feb 03; 6(2):460-70. PubMed ID: 17267661
    [Abstract] [Full Text] [Related]

  • 20. BLyS and APRIL in rheumatoid arthritis.
    Seyler TM, Park YW, Takemura S, Bram RJ, Kurtin PJ, Goronzy JJ, Weyand CM.
    J Clin Invest; 2005 Nov 03; 115(11):3083-92. PubMed ID: 16239971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.